Normal development of myeloid cells and the role of immature myeloid cells in chronic inflammation and carcinogenesis of the colorectal carcinoma
Normal development of myeloid cells and the role of immature myeloid cells in chronic inflammation and carcinogenesis of the colorectal carcinoma
批准号:
218451922
负责人:
Privatdozent Dr. Bernhard Renz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2013-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal addresses the link between inflammation and cancer and seeks to define the role of myeloid progenitors in cancer. The enzyme histidine decarboxylase (HDC), which catalyzes the conversion of L-histidine to histamine, plays a key role in the regulation of numerous physiologic processes. While HDC has now been well studied as a regulator of acid secretion downstream of CKK-¿/gastrin receptor signalling, the group of Timothy Wang, MD has recently identified a critical function of histidine decaboxylase (HDC) in early immature myeloid cells (IMCs) that characterizes both myeloid derived suppressor cells (MDSCs) and tumor associated neutrophils (TANs). Thus, in the described studies, HDC will be used as a marker to investigate the role of these cell types in cancer initiation and progression. They have also identified a key role for histamine in differentiation and maturation of myeloid cells and thus there is a potential target for modulating cancer risk. It is believed that this work has the potential to alter the paradigm for myeloid cells and their role in cancer. Immature myeloid cells, such as MDSCs and TANs, have been shown to accumulate in human cancers and contribute to the development and progression of cancer. The proposed studies will define further the utility of HDC as a novel marker for immature myeloid cells that contribute to cancer and the role of histamine in possibly suppressing MDSCs/TANs. In addition, the work may help elucidate strategies for targeting IMCs in order to prevent or treat gastrointestinal cancers.The following specific aims are proposed, each of which addresses a specific hypothesis:1. Are HDC-expressing CD11b+Gr1+ cells myeloid precursors that give rise to mature monocytes and granulocytes and other cell types?2. What is the effect of HDC-deficiency and carcinogenesis on spleen vs. bone marrow maturation?3. How are HDC-expressing IMCs recruited during carcinogenic stimuli?
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
-
批准号:82371668
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:乔云波
-
依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
-
批准号:82371276
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:严佳
-
依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
TMEM30A介导的磷脂酰丝氨酸外翻促进毛细胞-SGN突触发育成熟的机制研究
-
批准号:82371172
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨光
-
依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
-
批准号:82372014
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:魏伟军
-
依托单位:
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
-
批准号:32070202
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:汪泉
-
依托单位:
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
-
批准号:--
-
项目类别:--
-
资助金额:40万元
-
批准年份:2020
-
负责人:Vikrant Gupta
-
依托单位:
细胞核分布基因NudCL2在细胞迁移及小鼠胚胎发育过程中的作用及机制研究
-
批准号:31701214
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:张雯
-
依托单位: